{
    "clinical_study": {
        "@rank": "21919", 
        "arm_group": [
            {
                "arm_group_label": "Oral Granisetron + Dexamethasone", 
                "arm_group_type": "Experimental", 
                "description": "1 mg Granisetron in the morning\n1 Metoclopramide placebo in the afternoon\n1 mg Granisetron in the evening 4 mg Dexamethasone in the morning"
            }, 
            {
                "arm_group_label": "Metoclopramide + Dexamethasone", 
                "arm_group_type": "Experimental", 
                "description": "20 mg Metoclopramide (1 x morning, 1 x afternoon, 1 x evening) 4 mg Dexamethasone in the morning"
            }
        ], 
        "brief_summary": {
            "textblock": "RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients\n      treated with chemotherapy. It is not known whether receiving dexamethasone with granisetron\n      is more effective than receiving dexamethasone with metoclopramide for reducing the side\n      effects of chemotherapy.\n\n      PURPOSE: Randomized phase III trial to compare the effectiveness of dexamethasone with\n      either granisetron or metoclopramide in patients treated with chemotherapy."
        }, 
        "brief_title": "Drugs to Reduce the Side Effects of Chemotherapy", 
        "completion_date": {
            "#text": "August 1999", 
            "@type": "Actual"
        }, 
        "condition": [
            "Nausea and Vomiting", 
            "Unspecified Adult Solid Tumor, Protocol Specific"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Nausea", 
                "Vomiting"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Compare the clinical efficacy and safety of Granisetron or Metoclopramide in\n      combination with Dexamethasone in the prophylaxis of delayed nausea and vomiting induced by\n      emetogenic cancer chemotherapy in patients with or without emesis in the acute phase.\n\n      OUTLINE: This is a randomized, double blind study. Patients are stratified by prior\n      chemotherapy (yes vs no), regular alcohol consumption (yes vs no), and prior chemotherapy\n      regimen (cisplatin/carboplatin vs others). Patients receive dexamethasone and granisetron by\n      mouth bid on day 0. Patients are then randomized to receive either granisetron or\n      metoclopramide with dexamethasone concurrently with chemotherapy. Arm I: Patients receive\n      granisetron by mouth bid on days 1-5. Dexamethasone and a placebo are administered by mouth\n      once daily on days 1-5. Arm II: Patients receive metoclopramide by mouth tid on days 1-5.\n      Dexamethasone is administered by mouth once daily on days 1-5. Patients must complete a\n      diary card daily for 6 days.\n\n      PROJECTED ACCRUAL: This study will accrue 360 patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Scheduled to receive a first course of highly emetogenic single\n        day cancer chemotherapy regimens including: Cisplatin at least 50 mg/m2 Carboplatin at\n        least 300 mg/m2 Dacarbazine at least 500 mg/m2 Doxorubicin at least 40 mg/m2 Epirubicin at\n        least 60 mg/m2 Ifosfamide at least 1200 mg/m2 Cyclophosphamide at least 600 mg/m2\n\n        PATIENT CHARACTERISTICS: Age: 18 and over Performance status: Not specified Life\n        expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not\n        specified Other: Must be able to complete diary card (fluent in German, French, or\n        Italian) No severe concurrent illness No other etiologies that cause vomiting, including:\n        Gastrointestinal obstruction Hypercalcemia CNS metastases No active peptic ulceration No\n        prior gastrointestinal bleeding due to peptic ulcer No moderate to severe nausea or any\n        vomiting in the 24 hours prior to chemotherapy Not pregnant or lactating\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: At least 6 months\n        since prior chemotherapy Concurrent etoposide and fluorouracil allowed (days 1-5) No\n        chemotherapy before day 0 of study Endocrine therapy: Not specified Radiotherapy: Not\n        specified Surgery: Not specified Other: No other concurrent antiemetics No concurrent high\n        dose benzodiazepines No concurrent psychotropic agents"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "267", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00003213", 
            "org_study_id": "SAKK 90/95", 
            "secondary_id": [
                "SWS-SAKK-90/95", 
                "EU-97035", 
                "CDR0000066073"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Oral Granisetron + Dexamethasone", 
                    "Metoclopramide + Dexamethasone"
                ], 
                "description": "4 mg Dexamethasone in the morning", 
                "intervention_name": "dexamethasone", 
                "intervention_type": "Drug", 
                "other_name": "dexamethasone acetate"
            }, 
            {
                "arm_group_label": "Oral Granisetron + Dexamethasone", 
                "description": "1 mg Granisetron in the morning", 
                "intervention_name": "granisetron hydrochloride", 
                "intervention_type": "Drug", 
                "other_name": "Kytril\u00ae"
            }, 
            {
                "arm_group_label": "Metoclopramide + Dexamethasone", 
                "description": "20 mg Metoclopramide (1 x morning, 1 x afternoon, 1 x evening)", 
                "intervention_name": "metoclopramide hydrochloride", 
                "intervention_type": "Drug", 
                "other_name": "Metozolv\u00ae"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Dexamethasone acetate", 
                "Dexamethasone", 
                "Metoclopramide", 
                "Granisetron", 
                "Dexamethasone 21-phosphate", 
                "BB 1101"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "unspecified adult solid tumor, protocol specific", 
            "nausea and vomiting"
        ], 
        "lastchanged_date": "July 10, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "zip": "20141"
                    }, 
                    "name": "Istituto Europeo Di Oncologia"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aarau", 
                        "country": "Switzerland", 
                        "zip": "5001"
                    }, 
                    "name": "Kantonspital Aarau"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Basel", 
                        "country": "Switzerland", 
                        "zip": "CH 4051"
                    }, 
                    "name": "Office of Walter Weber-Stadelman"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Basel", 
                        "country": "Switzerland", 
                        "zip": "CH-4031"
                    }, 
                    "name": "University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bern", 
                        "country": "Switzerland", 
                        "zip": "CH-3010"
                    }, 
                    "name": "Inselspital, Bern"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Geneva", 
                        "country": "Switzerland", 
                        "zip": "CH-1211"
                    }, 
                    "name": "Hopital Cantonal Universitaire de Geneva"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lugano", 
                        "country": "Switzerland", 
                        "zip": "CH-6900"
                    }, 
                    "name": "Istituto Oncologico della Svizzera Italiana"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Solothurn", 
                        "country": "Switzerland", 
                        "zip": "4500"
                    }, 
                    "name": "Burgerspital, Solothurn"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zurich", 
                        "country": "Switzerland", 
                        "zip": "CH-8008"
                    }, 
                    "name": "Klinik Hirslanden"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zurich", 
                        "country": "Switzerland", 
                        "zip": "8063"
                    }, 
                    "name": "City Hospital Triemli"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Italy", 
                "Switzerland"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-Blind Trial to Compare the Clinical Efficacy and Safety of Granisetron vs. Metoclopramide Combined to Dexamethasone in the Prophylaxis of Chemotherapy-Induced Delayed Emesis", 
        "overall_official": {
            "affiliation": "European Institute of Oncology", 
            "last_name": "Matti S. Aapro, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 1999", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Complete and partial control of emesis", 
            "safety_issue": "No", 
            "time_frame": "Total control of emesis on every one of the 5 days following the acute phase"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00003213"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": [
            {
                "PMID": "12562658", 
                "citation": "Aapro MS, Thuerlimann B, Sessa C, De Pree C, Bernhard J, Maibach R; Swiss Group for Clinical Cancer Research. A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis. Ann Oncol. 2003 Feb;14(2):291-7."
            }, 
            {
                "PMID": "11773155", 
                "citation": "Bernhard J, Maibach R, Thurlimann B, Sessa C, Aapro MS; Swiss Group for Clinical Cancer Research. Patients' estimation of overall treatment burden: why not ask the obvious? J Clin Oncol. 2002 Jan 1;20(1):65-72."
            }, 
            {
                "citation": "Aapro MS, Sessa C, Thurlimann B, et al.: SAKK 90/95: a randomized double-blind trial to compare the clinical efficacy of granisetron to metoclopramide, both combined to dexamethasone in the prophylaxis of chemotherapy induced delayed emesis. [Abstract] Proceedings of the American Society of Clinical Oncology 19: A2360, 2000."
            }
        ], 
        "source": "Swiss Group for Clinical Cancer Research", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Swiss Group for Clinical Cancer Research", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 1996", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "July 2012"
    }, 
    "geocoordinates": {
        "Burgerspital, Solothurn": "47.209 7.538", 
        "City Hospital Triemli": "47.369 8.539", 
        "Hopital Cantonal Universitaire de Geneva": "46.198 6.142", 
        "Inselspital, Bern": "46.948 7.445", 
        "Istituto Europeo Di Oncologia": "45.464 9.188", 
        "Istituto Oncologico della Svizzera Italiana": "46.007 8.952", 
        "Kantonspital Aarau": "47.391 8.046", 
        "Klinik Hirslanden": "47.369 8.539", 
        "Office of Walter Weber-Stadelman": "47.557 7.593", 
        "University Hospital": "47.557 7.593"
    }
}